Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495714 | SCV000578792 | likely benign | Breast-ovarian cancer, familial 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000215165 | SCV000273879 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000227981 | SCV000283229 | likely benign | Hereditary breast and ovarian cancer syndrome | 2017-12-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000426931 | SCV000527404 | likely benign | not specified | 2016-05-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000426931 | SCV000600576 | likely benign | not specified | 2017-07-11 | criteria provided, single submitter | clinical testing | |
Color | RCV000215165 | SCV000906076 | likely benign | Hereditary cancer-predisposing syndrome | 2018-08-21 | criteria provided, single submitter | clinical testing |